start trial long-term follow-up of onasemnogene abeparvovec in sma
Published 3 years ago • 110 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
3:35
str1ve trial of onasemnogene abeparvovec for sma
-
4:06
spr1nt trial of onasemnogene abeparvovec for sma
-
3:33
onasemnogene clinical trial data
-
8:50
zolgensma and the start trial for sma
-
2:50
latest data from onasemnogene clinical trials
-
47:27
2021 virtual sma conference: understanding treatment, trials and care of a pre-symptomatic diagnosis
-
34:54
identifying, diagnosing and treating patients with later-onset sma
-
36:52
importance of long-term follow-up after treatment_ part of the scid compass series
-
2:17
extended follow-up of the master trial
-
2:06
long-term follow-up from the uk myeloma xi trial
-
1:00:52
lunch & learn: the pathway to an approval
-
2:26
gene therapy trials support early treatment and safety
-
1:40
the mongersen trial
-
0:45
auto-allo tandem sct for myeloma
-
6:10
when should patients receive follow-up mutational tests?
-
5:03
prior authorization and payer test coverage of sma
-
4:56
post hoc analysis: phase 3 asclepios i and ii trials in relapsing ms
-
1:25
trial to evaluate eprenetapopt-azacytidine combo in tp53 mds completes enrollment
-
4:57
open-label extension study of lecanemab in early alzheimer’s disease